|
|
|
Volumn 55, Issue 2, 2014, Pages 239-243
|
|
[Development of cytomegalovirus antigenemia in 3 patients with B cell lymphoma treated with bendamustine monotherapy].
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
BENDAMUSTINE;
BIOLOGICAL MARKER;
CHLORMETHINE DERIVATIVE;
DRUG DERIVATIVE;
GANCICLOVIR;
VALGANCICLOVIR;
VIRUS ANTIGEN;
ADULT;
AGED;
B CELL LYMPHOMA;
BLOOD;
CASE REPORT;
CD4 LYMPHOCYTE COUNT;
CHEMICALLY INDUCED DISORDER;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFECT;
FEMALE;
HUMAN;
IMMUNOLOGY;
MALE;
MIDDLE AGED;
OPPORTUNISTIC INFECTION;
PHYSIOLOGY;
REVIEW;
TREATMENT OUTCOME;
VIRUS ACTIVATION;
ADULT;
AGED;
ANTIGENS, VIRAL;
ANTIVIRAL AGENTS;
BIOLOGICAL MARKERS;
CD4 LYMPHOCYTE COUNT;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTIONS;
FEMALE;
GANCICLOVIR;
HUMANS;
LYMPHOMA, B-CELL;
MALE;
MIDDLE AGED;
NITROGEN MUSTARD COMPOUNDS;
OPPORTUNISTIC INFECTIONS;
TREATMENT OUTCOME;
VIRUS ACTIVATION;
|
|
EID: 84901405553
PISSN: 04851439
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (0)
|
